Overview
KPV (Lysine–Proline–Valine) is a short-chain peptide fragment derived from α-MSH (alpha-melanocyte-stimulating hormone), studied in biochemical and inflammatory research for its role in modulating immune signaling pathways. In laboratory settings, it is of particular interest for its interaction with inflammatory mediators and cellular repair mechanisms. This compound is supplied by ReGen-X exclusively for scientific and laboratory research.
⸻
Mechanism of Action (Research Context)
In controlled research environments, KPV has been observed to influence key inflammatory and cellular pathways:
•Cytokine modulation – associated with the downregulation of pro-inflammatory cytokines such as TNF-α and IL-6
•NF-κB pathway interaction – studied for its role in regulating nuclear factor kappa B signaling involved in inflammation
•Immune response regulation – contributes to balancing inflammatory signaling in cellular models
These mechanisms make KPV a relevant compound in research focused on inflammation and cellular resilience.
⸻
Research Summary
KPV has been evaluated in laboratory and experimental models for its potential role in:
• Inflammatory pathway modulation
• Gastrointestinal and epithelial barrier research
• Immune system signaling dynamics
• Cellular recovery and stress-response mechanisms
Its targeted activity makes it valuable for studying localized inflammation and immune regulation in complex biological systems.
⸻
Product Specifications
•Compound: KPV (Lysine–Proline–Valine)
•Quantity: 10 mg
•Form: Lyophilised research peptide
•Included: Bacteriostatic water (for laboratory reconstitution only)
•Storage: Refrigerated per laboratory standards
⸻
Important Research Use Notice
This product is sold strictly for laboratory and scientific research use only. It is not a medicine, not a supplement, and not approved for human or veterinary use. No medical, therapeutic, or health claims are made or implied.






Reviews
There are no reviews yet.